Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Are Three Big Pharma Firms Circling This Biotech Stock?

It was the very first stock we recommended on the very first day we published Private Briefing.

It soared as much as 211% and continues to hold 170% above our original recommendation price.

Indeed, each time the stock has backed off, we've re-recommended it.

Now new reports have emerged that say this biotech could well be a takeover target.

The company is Belgium-based Galapagos NV (OTC ADR: GLPYY). And I know from the notes that I received that a lot of you bought this stock. So I wanted to give you the lowdown on this buyout speculation.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK